Who is affected by this change?

This affects Independence Blue Cross Oncology, Hematology providers on Commercial plans.

When does this change take effect?

This change is effective Dec 29, 2025.

Back to dashboard

CommercialCoverageMedium impact

08.02.42, Penpulimab-kcqx

Independence Blue Cross·Oncology, Hematology·Pharmacy

Effective date

Dec 29, 2025

We identified it

Jun 19, 2026

Days to comply

—

Summary

A new pharmacy policy for Penpulimab-kcqx (likely a cancer immunotherapy drug) has been created for commercial insurance plans. This policy will establish coverage criteria, prior authorization requirements, or billing guidelines for this medication starting December 29, 2025.

Action Required

Action needed

Before December 29, 2025: Review the complete policy document at the provided URL to understand specific coverage criteria, prior authorization requirements, and billing procedures for Penpulimab-kcqx. Update pharmacy benefit management protocols and inform providers who prescribe oncology medications about any new requirements.

Related policy hubs

Independence Blue Cross policies Oncology Hematology